Articles scientifiques

Randomized Phase II Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer.

Auteurs : Baselga J, Gómez P, Greil R, Braga S, Climent MA, Wardley AM, Kaufman B, Stemmer SM, Pêgo A, Chan A, Goeminne JC, Graas MP, Kennedy MJ, Ciruelos Gil EM, Schneeweiss A, Zubel A, Groos J, Melezínková H, Awada A
Année : 2013
Journal : J. Clin. Oncol.
Volume : 31(20)
Pages : 2586-92

Imbalance between supply and need of medical oncologists in Belgium

Auteurs : Dhondt V, Benahmed A, De Wever L, Dirix L, de Valeriola D
Année : 2013
Journal : Belgian J Medical Oncology
Volume : 7(2)
Pages : 38-45

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.

Auteurs : Fayyad-Kazan H, Bitar N, Najar M, Lewalle P, Fayyad-Kazan M, Badran R, Hamade E, Daher A, Hussein N, Eldirani R, Berri F, Vanhamme L, Burny A, Martiat P, Rouas R, Badran B
Année : 2013
Journal : J Transl Med
Volume : 11(1)
Pages : 31

Clinical practice-changing trials: the HERA study paradigm.

Auteurs : Zardavas D, Ades F, de Azambuja E
Année : 2013
Journal : Expert Rev Anticancer Ther
Volume : 13(11)
Pages : 1249-56

Performance and abnormal cell flagging comparisons of three automated blood cell counters: Cell-Dyn Sapphire, DxH-800, and XN-2000.

Auteurs : Hotton J, Broothaers J, Swaelens C, Cantinieaux B
Année : 2013
Journal : Am J. Clin. Pathol.
Volume : 140(6)
Pages : 845-52

Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.

Auteurs : Aftimos P, Wiedig M, Langouo Fontsa M, Awada A, Ghanem G, Journe F
Année : 2013
Journal : Int J Oncol
Volume : 43(3)
Pages : 919-26

Contributions of SPECT/CT imaging to the lymphoscintigraphic investigations of the lower limb lymphedema.

Auteurs : Baulieu F, Bourgeois P, Maruani A, Belgrado JP, Tauveron V, Lorette G, Vaillant L
Année : 2013
Journal : Lymphology
Volume : 46(3)
Pages : 106-19

Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature.

Auteurs : Dumitrescu C, Lossignol D
Année : 2013
Journal : Case Rep Oncol Med
Volume : 2013
Pages : 154674

Discrepancies in cancer incidence and mortality and its relationship to health expenditure in the 27 European Union member states.

Auteurs : Ades F, Senterre C, de Azambuja E, Sullivan R, Popescu R, Parent F, Piccart-Gebhart M
Année : 2013
Journal : Ann Oncol
Volume : 24(11)
Pages : 2897-902

Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial.

Auteurs : Azim HA, Agbor-Tarh D, Bradbury I, Dinh P, Baselga J, Di Cosimo S, Greger JG, Smith I, Jackisch C, Kim SB, Aktas B, Huang CS, Vuylsteke P, Hsieh RK, Dreosti L, Eidtmann H, Piccart-Gebhart M, de Azambuja E
Année : 2013
Journal : J. Clin. Oncol.
Volume : 31(36)
Pages : 4504-11

Stratified Medicine: a call for action

Auteurs : Awada A, Annemans L, Broeckx D, Pauwels P, Simoens S, Van Belle S, van Cutsem E, Van Hoof E, De Greve J
Année : 2013
Journal : Belgian J Medical Oncology
Volume : 7(1)
Pages : 15-19

Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma. (epub online oct 2012)

Auteurs : Digonnet A, Hamoir M, Andry G, Vander Poorten V, Haigentz M, Langendijk JA, De Bree R, Hinni ML, Mendenhall WM, Paleri V, Rinaldo A, Werner JA, Takes RP, Ferlito A
Année : 2013
Journal : Eur Arch Otorhinolaryngol
Volume : 270(7)
Pages : 1981-9

Differentiated thyroid carcinoma: defining new paradigms for the post-operative management.

Auteurs : Durante C, Costante G, Filetti S
Année : 2013
Journal : Endocr Relat Cancer
Volume : 20(4)
Pages : R141-54

Microvesicles and Cancer.

Auteurs : Azerad MA, Debaugnies F, Demulder A, Bron D, Efira A
Année : 2013
Journal : Belgian J Hematology
Volume : 4
Pages : 1

Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial.

Auteurs : Oakman C, Francis PA, Crown J, Quinaux E, Buyse M, de Azambuja E, Margeli Vila M, Andersson M, Nordenskjöld B, Jakesz R, Thürlimann B, Gutiérrez J, Harvey V, Punzalan L, Dell orto P, Larsimont D, Steinberg I, Gelber Rd, Piccart-Gebhart M, Viale G, Di Leo A
Année : 2013
Journal : Ann Oncol
Volume : 24(5)
Pages : 1203-11

Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial.

Auteurs : Azim HA, Rothé F, Aura CM, Bavington M, Maetens M, Rouas G, Gebhart G, Gamez C, Eidtmann H, Baselga J, Piccart-Gebhart M, Ellis C, Vuylsteke P, Cure H, Domont J, Ferro A, Toral-Peña JC, de Azambuja E, Sotiriou C, Di Cosimo S, Ignatiadis M
Année : 2013
Journal : Breast
Volume : 22(6)
Pages : 1060-5

Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.

Auteurs : Pritchard KI, Burris HA, Ito Y, Rugo HS, Dakhil S, Hortobagyi GN, Campone M, Csöszi T, Baselga J, Puttawibul P, Piccart-Gebhart M, Heng D, Noguchi S, Srimuninnimit V, Bourgeois H, Gonzalez Martin A, Osborne K, Panneerselvam A, Taran T, Sahmoud T, Gnant M
Année : 2013
Journal : Clin Breast Cancer
Volume : 13(6)
Pages : 421-432.e8

5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines but modulates genes that are involved in adaptation in vitro.

Auteurs : Dom G, Chico Galdo V, Tarabichi M, Tomás G, Hébrant A, Andry G, De Martelaer V, Libert F, Leteurtre E, Dumont JE, Maenhaut C, van Staveren W
Année : 2013
Journal : Thyroid
Volume : 23(3))
Pages : 317-28

The European lung corner.

Auteurs : Sculier JP
Année : 2013
Journal : Eur. Respir. J.
Volume : 42(6)
Pages : 1433-4

Targeting RANKL in breast cancer: bone metastasis and beyond.

Auteurs : Azim H, Azim HA
Année : 2013
Journal : Expert Rev Anticancer Ther
Volume : 13(2)
Pages : 195-201